Daily vitamin E supplementation does not improve metabolic and glycemic control in type 2 diabetic patients: A double blinded randomized controlled trial

Journal of Diabetes

Volumn 5, Issue 1, 2013, Pages 57-58

  Shab Bidar, Sakineh ^a   Mazloum, Zohreh ^b   Mousavi Shirazifard, Zahra ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Insulin resistance; Lipid profiles; Type 2 diabetes mellitus; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LETTER; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; VITAMIN E;

EID: 84873456481     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2012.00206.x     Document Type: Letter

References (7)

1. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys. 2005; 43: 289-330.
2. Ford ES. Vitamin supplement use and diabetes mellitus incidence among adults in the United States. Am J Epidemiol. 2001; 153: 892-7.
3. Ward NC, Wu JH, Clarke MW et al.The effect of vitamin E on blood pressure in individuals with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. J Hypertens. 2007; 25: 227-34.
4. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-9.
5. Mayer-Davis EJ, Costacou T, King I et al.Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care. 2002; 25: 2172-7.
6. Milman U, Blum S, Shapira C et al.Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: A prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol. 2008; 28: 341-7.
7. Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005; 142: 37-46.